Oxford Asset Management’s Imunon IMNN Stock Holding History

Oxford Asset Management’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-89	Closed	-$25K	–	1811
2018 Q4	$25K	Buy	+89	New	+$36.9K	﹤0.01%	1733

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Dillon & Associates Jackson, Michigan $726M AUM 18.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oxford Asset Management's IMNN Position: Q1 2019 in Review

Oxford Asset Management sold out of Imunon (IMNN) in Q1 2019, closing a stake of 89 shares — an estimated $25K sold.

Oxford Asset Management first reported a position in IMNN in Q4 2018 and held it in 1 quarter. The position peaked at $25K in Q4 2018. 17 funds tracked by Wall St. Rank hold IMNN as of Q1 2019.

Oxford Asset Management reported no remaining Imunon position as of Q1 2019 after selling out during the quarter.
Oxford Asset Management sold 89 Imunon shares in Q1 2019, an estimated $25K.
Oxford Asset Management first reported a position in Imunon in Q4 2018 and held it in 1 quarter.
Oxford Asset Management's Imunon position peaked at $25K in Q4 2018.
17 funds tracked by Wall St. Rank held Imunon as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.